Stay updated with breaking news from Comera Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of biologic medicines to improve
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Free Report) major shareholder David Soane purchased 273,838 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were purchased at an average cost of $0.51 per share, for a total transaction of $139,657.38. Following the transaction, the insider now directly owns 225,648 […]
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Free Report) major shareholder David Soane bought 273,838 shares of the business’s stock in a transaction on Monday, July 31st. The stock was bought at an average cost of $0.51 per share, for a total transaction of $139,657.38. Following the purchase, the insider now directly owns 225,648 […]
– Ownership of proprietary sourcing for U.S.-manufactured lead SQore excipients allows for full control over supply chain and greater flexibility to...
'We have people taking two or three different injectable drugs every other week.'